Halozyme director Matthew L. Posard sells 5,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Halozyme Therapeutics, Inc. director Matthew L. Posard sold 5,000 common shares on November 18, 2026 in two reported transactions: 3,400 shares at a weighted-average price of $96.1730 per share and 1,600 shares at $96.9740 per share. The sales were made under a written Rule 10b5-1 trading plan adopted on June 15, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 3,400 | $96.173 | $327K |
| Sale | Common Stock F1, F3 | 1,600 | $96.974 | $155K |
Footnotes (3)
- F1. The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on June 15, 2026 in accordance with Rule 10b5-1.
- F2. Represents a weighted average sales price per share. The shares were sold at prices ranging from $95.680 to $96.590. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3. Represents a weighted average sales price per share. The shares were sold at prices ranging from $96.700 to $97.490. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Key Figures
Key Terms
Rule 10b5-1 regulatory
weighted average sales price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What price ranges did Matthew L. Posard report for his HALO stock sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.